Autolus Therapeutics plc (AUTL) Return On Equity % [USD] 2018 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Autolus Therapeutics plc quarterly/annual Return On Equity history and growth rate from 2018 to 2024.
  • Autolus Therapeutics plc Return On Equity for the quarter ending March 31, 2024 was -80.2 %, a 24.5% decline year-over-year.
  • Autolus Therapeutics plc annual Return On Equity for 2023 was -106 %, a 67.9% decline from 2022.
  • Autolus Therapeutics plc annual Return On Equity for 2022 was -63 %.
  • Autolus Therapeutics plc annual Return On Equity for 2020 was -57.2 %, a 20.2% decline from 2019.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -80.2 -15.8 -24.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -106 -42.8 -67.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -64.9 Jul 1, 2023 Sep 30, 2023
Q2 2023 -64.9 Apr 1, 2023 Jun 30, 2023
Q1 2023 -64.4 Jan 1, 2023 Mar 31, 2023
Q4 2022 -63 Oct 1, 2022 Dec 31, 2022
Q1 2021 -57.9 -12.3 -27% Jan 1, 2021 Mar 31, 2021
Q4 2020 -57.2 -9.62 -20.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -54 -13.3 -32.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -48.6 -13.1 -36.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -45.6 -17.5 -62.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -47.6 -21.4 -81.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -40.7 -17.9 -78.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -35.5 Apr 1, 2019 Jun 30, 2019
Q1 2019 -28.1 Jan 1, 2019 Mar 31, 2019
Q4 2018 -26.2 Oct 1, 2018 Dec 31, 2018
Q3 2018 -22.7 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.